Syndex Bio

Precede Biosciences

The company develops an epigenomic liquid biopsy platform for biopharmaceutical companies and researchers to profile gene expression and disease biology from blood samples.

BioSkryb

This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.

Romix Bio

This company develops a molecular scan platform using cell-free RNA liquid biopsy and artificial intelligence for disease profiling and drug development for biotechnology customers.

Ellis Bio

This company develops bisulfite conversion kits for DNA methylation analysis, serving clinical and academic researchers in the epigenomics and oncology sectors.

Molecular Stethoscope

This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.

3X Genetics

This company develops long-read genetic testing technology and diagnostics for biopharma companies to identify patients with rare repeat expansion disorders.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

Single molecule diagnostics

This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.